Yong Tang
China Pharmaceutical University
ORCID: 0000-0001-9478-5205Also affiliated with Chengdu Women's and Children's Central Hospital
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Papers
Driven by 3 papers. Top paper: “Pembrolizumab in HER2-Positive Gastric Cancer”.
Akihito Kawazoe, Yuxian Bai, Jianming Xu, Sara Lonardi, Jean Phillipe Metges +21 more
Pangr: A Behavior-Based Automatic Vulnerability Detection and Exploitation Framework
Jingyuan Wang, Zelin Rong, Xianya Mi, Fangyu Gai, Yong Tang +2 more
Wei Lu, Xuan Qiu, Shu Yang, Chen Li, Wei Zhang +2 more